Home › Drug Types › JAK Inhibitors

JAK Inhibitors: Names, Generics and Prices

JAK inhibitors (Janus kinase inhibitors) are a class of medicines that calm an overactive immune system. They treat conditions such as rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and eczema, and some treat certain blood disorders.

8 medicines listed2 of 8 have a U.S. genericFrom $0.78 per daily dose

Written by the eDrugSearch team · Medical review: Dr. Diana Rangaves, PharmD, November 21, 2026 · Updated November 21, 2026 · Prices checked Nov 5 to Nov 12, 2026

We compare prices. We do not sell medicine.

ListHow they workUsesSide effectsPay lessFAQSources

Illustration of a shield, tablets and a pill bottle

Key takeaways

  • Rheumatoid arthritis, psoriatic arthritis and ulcerative colitis: tofacitinib (Xeljanz) is used for these conditions.1
  • 2 of the 8 medicines on this list have an FDA-approved generic on sale in the U.S.10 The ones with no FDA-approved generic are Cibinqo, Litfulo, Jakafi, Opzelura and Rinvoq. A generic of Olumiant is FDA-approved but not on sale yet.
  • Only your doctor can say which medicine is right for you. Never stop or change a medicine on your own.

List of JAK inhibitors (names and prices)

Each medicine links to its own price page. Drug types come from the FDA.11

Pills for inflammatory conditions

FDA's 2021 safety warning covers the JAK inhibitor pills used for arthritis and other inflammatory conditions: Xeljanz, Olumiant and Rinvoq.2

Prices are the lowest we found for one pill or other unit (mL, gram, pen, inhaler, patch, packet or dose). The strength is under each price, so compare the same strength on the drug page. Open a drug page for 90-day totals, every pack size and shipping.

MedicineU.S. generic?Lowest U.S. priceLowest price abroadCompare
BaricitinibBrand: Olumiant✗ Not sold in U.S. yetA generic is FDA-approved but not on sale.No U.S. pharmacy price yet$43.04 per tabletbrand Olumiant 2 mg · shipping included · pharmacy abroad · checked Nov 12See prices
TofacitinibBrand: Xeljanz✓ Yes$0.78 per daily dosegeneric 5 mg · shipping included · U.S. online pharmacy · checked Nov 12$2.93 per daily dosegeneric 5 mg · shipping included · pharmacy abroad · checked Nov 12Tofacitinib pricesXeljanz prices
Tofacitinib ERBrand: Xeljanz XR✓ Yes$172.15 per tabletbrand Xeljanz XR 11 mg · shipping included · U.S. online pharmacy · checked Nov 12$30.13 per tabletbrand Xeljanz XR 11 mg · shipping included · pharmacy abroad · checked Nov 12See prices
UpadacitinibBrand: Rinvoq✗ Brand onlyNo U.S. pharmacy price yet$45.50 per tabletbrand Rinvoq 15 mg · shipping included · pharmacy abroad · checked Nov 12See prices

This list shows common non-controlled prescription medicines that have a price page on our site. It is not a complete list. Your doctor may prescribe others.

Blood disorder medicine

Jakafi is not used for arthritis, so it was not part of that 2021 update.2

MedicineU.S. generic?Lowest U.S. priceLowest price abroadCompare
RuxolitinibBrand: Jakafi✗ Brand onlyNo U.S. pharmacy price yet$105.97 per tabletbrand Jakafi 10 mg · shipping included · pharmacy abroad · checked Nov 12See prices

Other medicines in this group

MedicineTypeU.S. generic?Lowest U.S. priceLowest price abroadCompare
AbrocitinibBrand: CibinqoJAK inhibitor✗ Brand onlyNo U.S. pharmacy price yet$74.56 per tabletbrand Cibinqo 100 mg · shipping included · pharmacy abroad · checked Nov 12See prices
RitlecitinibBrand: LitfuloJAK inhibitor✗ Brand onlyNo U.S. pharmacy price yet$82.32 per capsulebrand Litfulo 50 mg · shipping included · pharmacy abroad · checked Nov 12See prices
Ruxolitinib creamBrand: OpzeluraJAK inhibitor✗ Brand onlyNo U.S. pharmacy price yet$13.26 per gbrand Opzelura 1.5% · before shipping · pharmacy abroad · checked Nov 5See prices

How they work

They block JAK enzymes inside cells. These enzymes pass along signals that turn on parts of the immune system, so blocking them lowers immune activity.3

What they are used for

  • Rheumatoid arthritis, psoriatic arthritis and ulcerative colitis: tofacitinib (Xeljanz) is used for these conditions.1
  • Eczema (atopic dermatitis) that other medicines have not controlled: abrocitinib (Cibinqo) and upadacitinib (Rinvoq) are approved for it.6
  • Severe hair loss (alopecia areata): baricitinib (Olumiant) is approved for it, as well as for rheumatoid arthritis.5
  • Blood disorders: ruxolitinib (Jakafi) treats myelofibrosis and polycythemia vera.7
  • Skin use: ruxolitinib cream (Opzelura) is rubbed on the skin for mild to moderate eczema and for vitiligo.8
  • Severe hair loss from alopecia areata: ritlecitinib (Litfulo) is approved for adults and teens 12 and older.9

Common side effects and warnings

Common side effects of tofacitinib include colds and other upper airway infections, sore throat or stuffy nose, diarrhea and headache.3 Ask your pharmacist about your own medicine.

Ways to pay less

  • Ask about a generic. 2 of the 8 medicines on this list have an FDA-approved generic on sale in the U.S.10 A generic of Olumiant is FDA-approved but not on sale yet. A generic works the same way as the brand and has the same active ingredient, strength and dosage form.14
  • Ask about a 90-day supply. Larger packs often cost less per unit.
  • Compare pharmacies. Open any drug page above to see prices at U.S. and international online pharmacies.
  • Check help programs. Some drug makers offer help for people who can’t afford their medicine. See our patient assistance programs guide.
  • Buying from abroad. Federal law generally doesn’t allow individuals to import prescription drugs. Under its personal importation policy, the FDA has long used enforcement discretion for some personal-use shipments, generally no more than a three-month supply (FDA). Congress declared in FD&C Act 804(j)(1), 21 U.S.C. 384(j)(1), that enforcement against individuals should focus on imports posing a significant threat to public health.13

How generics bring prices down

Example of a brand that costs $100. The FDA says one generic maker can lower prices by 30%, and five are linked to drops of nearly 85%. Real prices vary. Source: FDA, Generic drug facts.

Common questions

What are examples of JAK inhibitors?

Tofacitinib (Xeljanz), upadacitinib (Rinvoq), baricitinib (Olumiant), abrocitinib (Cibinqo) and ruxolitinib (Jakafi pills and Opzelura cream). Ritlecitinib (Litfulo) is another one.3456789

What is a JAK inhibitor for RA?

Tofacitinib, baricitinib and upadacitinib are FDA-approved for rheumatoid arthritis in adults who did not do well on a TNF blocker.345

What are the risks of JAK inhibitors?

FDA requires warnings about serious infections, heart attack or stroke, cancer, blood clots and death for the JAK inhibitors that treat arthritis and other inflammatory conditions.23

Is there a JAK inhibitor for eczema?

Yes. Abrocitinib (Cibinqo) and upadacitinib (Rinvoq) pills, and ruxolitinib cream (Opzelura), are approved for certain cases of atopic dermatitis.648

Which JAK inhibitors have a generic?

2 of the 8 medicines on this list have an FDA-approved generic on sale in the U.S.10 The ones with no FDA-approved generic are Cibinqo, Litfulo, Jakafi, Opzelura and Rinvoq. A generic of Olumiant is FDA-approved but not on sale yet.

Sources

  1. MedlinePlus (U.S. National Library of Medicine, NIH). Tofacitinib: MedlinePlus Drug Information. Accessed Nov 21, 2026 (revision date not captured)
  2. U.S. Food and Drug Administration (Drug Safety Communication). FDA requires warnings about increased risk of serious heart-related events, cancer, blood clots, and death for JAK inhibitors that treat certain chronic inflammatory conditions. Content current as of 12/07/2021
  3. U.S. Food and Drug Administration (FDA-approved drug label, via openFDA). XELJANZ / XELJANZ XR (tofacitinib) label. Label effective 2026-11-10
  4. U.S. Food and Drug Administration (FDA-approved drug label, via openFDA). RINVOQ (upadacitinib) label. Label effective 2026-06-30
  5. U.S. Food and Drug Administration (FDA-approved drug label, via openFDA). OLUMIANT (baricitinib) label. Label effective 2026-10-09
  6. U.S. Food and Drug Administration (FDA-approved drug label, via openFDA). CIBINQO (abrocitinib) label. Label effective 2026-10-15
  7. U.S. Food and Drug Administration (FDA-approved drug label, via openFDA). JAKAFI (ruxolitinib) label. Label effective 2026-07-20
  8. U.S. Food and Drug Administration (FDA-approved drug label, via openFDA). OPZELURA (ruxolitinib) cream label. Label effective 2026-06-30
  9. U.S. Food and Drug Administration (via openFDA / DailyMed). LITFULO (ritlecitinib) label. Label effective 2026-06-17
  10. FDA. Drugs@FDA: approved applications (generic ANDAs and new drug NDAs) and marketing status, read through openFDA, Nov 21, 2026
  11. National Library of Medicine. RxClass: FDA Established Pharmacologic Class for each medicine
  12. FDA drug labels (indications, adverse reactions and boxed warnings), via DailyMed / openFDA
  13. FDA. Personal importation
  14. FDA. Generic drug facts